Quarterly report pursuant to Section 13 or 15(d)

Business Acquisition - Schedule of Pro Forma Financial Information (Details)

v3.19.2
Business Acquisition - Schedule of Pro Forma Financial Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2018
Revenues $ 2,690,432 $ 5,736,418
Net loss (1,448,622) (3,599,608)
Net loss attributable to common shareholders $ (1,715,679) $ (3,866,665)
Loss per share- basic and diluted $ (0.03) $ (0.07)
RMS [Member]    
Revenues $ 2,441,007 $ 5,343,804
Net loss (362,722) (1,259,922)
Net loss attributable to common shareholders $ (362,722) $ (1,259,922)
Loss per share- basic and diluted $ (0.01) $ (0.01)
Medovex Corp [Member]    
Revenues $ 249,425 $ 392,614
Net loss (1,085,900) (2,339,686)
Net loss attributable to common shareholders $ (1,352,957) $ (2,606,743)
Loss per share- basic and diluted